Khanh Minh V.
- Country
- Norway
- Department
- Department of Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 62 partner sites.
Specializations
Hepatology & Metabolic Liver Disease
The investigator focuses on progressive liver conditions such as Non‑Alcoholic Steatohepatitis and associated fibrosis, exploring therapeutic strategies that address hepatic inflammation, steatosis, and metabolic risk factors.
- Non‑Alcoholic Steatohepatitis (NASH)
- Liver fibrosis regression
- Metabolic syndrome‑related liver injury
Research aims to integrate metabolic control with liver‑directed interventions to prevent cirrhosis and hepatocellular carcinoma.
Hematologic Oncology
In the realm of blood cancers, the investigator engages with acute and chronic malignancies, including Acute Myeloid Leukemia, myelodysplastic syndromes, and chronic lymphocytic leukemia, seeking novel targeted and immunologic approaches.
- Acute Myeloid Leukemia (AML)
- Myelodysplastic syndrome (MDS)
- Chronic Lymphocytic Leukemia (CLL)
Efforts emphasize precision medicine for older or frail patients and the integration of targeted agents with established chemotherapy.
Solid Tumor Oncology
The investigator’s portfolio includes major solid cancers such as Non‑Small Cell Lung Cancer, breast cancer subtypes, and colorectal carcinoma, with attention to molecular biomarkers and resistance mechanisms.
- Non‑Small Cell Lung Cancer (NSCLC)
- Triple‑negative breast cancer
- Metastatic colorectal cancer
- Renal cell carcinoma
Therapeutic development targets checkpoint inhibition, DNA‑damage response pathways, and tumor‑specific mutations.
Cardiovascular & Metabolic Disorders
Cardiovascular research centers on atherosclerotic disease and arrhythmia management, including Atherosclerotic Cardiovascular Disease and atrial fibrillation in high‑risk renal populations.
- Atherosclerotic Cardiovascular Disease (ASCVD)
- Atrial fibrillation with chronic kidney disease
- Heart failure with preserved ejection fraction
- Obesity‑related metabolic risk
Investigations aim to balance antithrombotic efficacy with bleeding safety in complex comorbid patients.
Immune‑Mediated Gastrointestinal & Systemic Diseases
In autoimmune and inflammatory conditions, the investigator addresses disorders such as Crohn’s disease, ulcerative colitis, and primary sclerosing cholangitis, focusing on biologic modulation and disease‑modifying outcomes.
- Crohn’s disease
- Ulcerative colitis
- Primary sclerosing cholangitis (PSC)
- Systemic autoimmune rheumatic disease‑associated interstitial lung disease
Therapeutic strategies prioritize cytokine inhibition, mucosal healing, and prevention of fibrosis across organ systems.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.